iNova Pharmaceuticals

iNova Pharmaceuticals is an international organisation that develops, markets and sells a wide-range of prescription medicines and non-prescription consumer health products to over 20 countries across Asia, Australia and New Zealand, and Africa.

Employing over 500 industry professionals over 3 continents, our vision is to deliver trusted, market-leading brands that improve people’s health and well-being everyday.

Our broad product portfolio spans therapeutic areas including weight management, cough, cold & flu, pain management, health supplements, dermatology, sun care and female health products.

With a rich product heritage, our flagship brands have appeared in family medicine cabinets for more than 50 years. We are committed to delivering effective, quality pharmaceutical products, manufactured to the highest international standards.

We strive to exceed our customers’ expectations in terms of product development and service delivery. We also pride ourselves on our strong and enduring relationships with healthcare professionals in our areas of expertise.

With a dynamic, collaborative and engaged workplace culture, we have in-house capabilities in sales and marketing, supply chain, quality, regulatory, medical, finance and legal. We challenge our team members to take ownership of our business, to embrace the increasing pace of consumer demand, and to be bold and challenge traditional ways of doing things.

Since a change of ownership in late 2017, the group has been actively looking to expand its product offerings through a focus on internally-driven product innovation and business development activity. We have a strong track record of acquiring, launching and building consumer health brands.

We are committed to socially and environmentally responsible procurement and have set high standards for the way we do business. We expect our suppliers and partners to also meet those standards.

This global website represents a gateway into iNova Pharmaceuticals’ products and services in all our markets.